课题基金 / 基金详情

DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS

DNA TOPOISOMERASES AS TARGET OF ACTION OF ANTICANCER DRUGS
DNA拓扑异构酶作为抗癌药物的作用靶点
批准号:
5201240
负责人:
Y POMMIER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

Y POMMIER的其他基金

相似基金

相关文献

中文摘要
翻译
DNA拓扑异构酶II(Top2)是多种肿瘤的细胞靶标。 最有效的抗癌药物(阿霉素、依托泊苷、米托蒽酮)。为 因此,它是抗癌药物开发的关键靶点之一。 我们还进一步证明了两种并吡唑衍生物 乳腺癌的临床试验是Top2抑制剂的序列 选择性与米托蒽醌相当。我们还描述了 通过与NCI的比较分析发现一种新的TOP2抑制剂 抗癌药物筛选数据库。 DNA拓扑异构酶I(Top1)已成为抗癌的重要靶点 自发现喜树碱是TOP1特异性毒物以来的研究 具有良好的抗癌活性。我们对烷基化反应的研究 喜树碱衍生物及其耐药点突变体 Top1提供了喜树碱阻断Top1的最直接证据 通过结合在酶上,因此可以诱导DNA重组。这 作用与喜树碱的细胞毒性有关,也与喜树碱的细胞毒性有关 TOP1的细胞功能。
英文摘要
DNA topoisomerase II (top2) is the cellular target of several among the most potent anticancer agents (doxorubicin, etoposide, mitoxanthrone). For this reason, it is one of the key targets in anticancer drug development. We have further demonstrated that two anthrapyrazoles derivatives in clinical trials for breast cancer are top2 inhibitors with a sequence selectivity comparable to that of mitoxantrone. We have also characterized a new top2 inhibitor that was found by Compare analysis of the NCI Anticancer Drug Screening Database. DNA topoisomerase I (top1) has become an essential target for anticancer research since the discovery that camptothecins are specific top1 poisons with promising anticancer activity. Our studies with an alkylating camptothecin derivative and with a camptothecin-resistant point mutant top1 have provided the most direct evidence that camptothecins block top1 by binding at the enzyme and therefore can induce DNA recombinations. This effect is relevant to the cytotoxicity of camptothecins and to the cellular functions of top1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
  • 批准号:
    3916548
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Y POMMIER
  • 依托单位:
TOPOISOMERASE II AS TARGET OF ACTION OF ANTICANCER DRUG
  • 批准号:
    3939497
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Y POMMIER
  • 依托单位:
PHARMACOLOGY OF THE HIV VIRAL DNA
  • 批准号:
    3838171
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Y POMMIER
  • 依托单位:
PROTEIN-ASSOCIATED DNA BREAKS AS INDICATOR OF TOPOISOMERASE INHIBITION
  • 批准号:
    3752315
  • 项目类别:
  • 资助金额:
    $0.0万
  • 财政年份:
    --
  • 负责人:
    Y POMMIER
  • 依托单位:
海外基金